<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas14841-bib-0023">
 <label>23</label>
 <mixed-citation publication-type="journal" id="cas14841-cit-0023">
  <string-name>
   <surname>Yamada</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Takahari</surname>
   <given-names>D</given-names>
  </string-name>, 
  <string-name>
   <surname>Matsumoto</surname>
   <given-names>H</given-names>
  </string-name>, et al. 
  <article-title>Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S‐1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open‐label, non‐inferiority, randomised phase 3 trial</article-title>. 
  <source xml:lang="en">Lancet Oncol</source>. 
  <year>2013</year>;
  <volume>14</volume>(
  <issue>13</issue>):
  <fpage>1278</fpage>‐
  <lpage>1286</lpage>.
  <pub-id pub-id-type="pmid">24225157</pub-id>
 </mixed-citation>
</ref>
